Plasma concentration of voriconazole under concomitant use of nirmatrelvir/ritonavir in patients with COVID-19: a multicenter retrospective study
The concomitant use of nirmatrelvir/ritonavir and voriconazole might be feasible, but the dosing of voriconazole needs further study.
Authors
- X B Zhang (ORCID: https://orcid.org/0009-0004-2099-0723)
- Lingyan Yu (ORCID: https://orcid.org/0000-0001-7828-139X)
- Qihui Kong
- Zhenwei Yu (ORCID: https://orcid.org/0000-0002-3776-2290)
- Hao Shi (ORCID: https://orcid.org/0000-0002-7585-6837)
Institutions
- Sir Run Run Shaw Hospital (CN)
- Northern Jiangsu People's Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Shaoxing People's Hospital (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.3389/fphar.2025.1654671
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40